NVAX

Novavax, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$7.70

Market Cap

$1.25B

Beta

2.63

P/E

3.5

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+64.69%

EPS Growth (YoY)+279.70%

Revenue CAGR 3Y-14.74%

P/E Ratio3.5

PEG Ratio0.01

FCF Yield-19.97%

Debt / Equity0.00

Interest Coverage20.6x

No credit card required

Already have an account? Sign in to view the full analysis for NVAX.